Cargando…

Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond

Outcomes for pediatric patients with acute myeloid leukemia (AML) remain poor, highlighting the need for improved targeted therapies. Building on the success of CD19-directed immune therapy for acute lymphocytic leukemia (ALL), efforts are ongoing to develop similar strategies for AML. Identifying t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Epperly, Rebecca, Gottschalk, Stephen, Velasquez, Mireya Paulina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072334/ https://www.ncbi.nlm.nih.gov/pubmed/32079207 http://dx.doi.org/10.3390/children7020014

Ejemplares similares

CAR-T cells and BiTEs in solid tumors: challenges and perspectives
por: Edeline, Julien, et al.
Publicado: (2021)

A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
por: Stone, Jennifer D., et al.
Publicado: (2012)

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
por: Epperly, Rebecca, et al.
Publicado: (2020)

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia
por: Deak, Dalma, et al.
Publicado: (2019)

BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML?
por: Allen, Cecily, et al.
Publicado: (2021)

Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy
por: Kujawski, Maciej, et al.
Publicado: (2019)

CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells
por: Hebbar, Nikhil, et al.
Publicado: (2022)

Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
por: Schreiner, Patrick, et al.
Publicado: (2021)

TEs or not TEs? That is the evolutionary question
por: Vaknin, Keren, et al.
Publicado: (2009)

Harnessing Immune Response in Acute Myeloid Leukemia
por: Riva, Carola, et al.
Publicado: (2023)

CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL
por: Epperly, Rebecca, et al.
Publicado: (2023)

Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy
por: Maron, Gabriela M., et al.
Publicado: (2022)

Acute myeloid leukemia therapeutics: CARs in the driver’s seat
por: Mardiros, Armen, et al.
Publicado: (2013)

Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
por: Kegyes, David, et al.
Publicado: (2022)

BiTE‐Secreting CAR‐γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors
por: Huang, Shi‐Wei, et al.
Publicado: (2023)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
por: Kumar, Bijender
Publicado: (2021)

Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia
por: Petgrave, Yonique P, et al.
Publicado: (2023)

Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma
por: Li, Gaowei, et al.
Publicado: (2021)

Beyond torture checklists: an exploratory study of the reliability and construct validity of the Torturing Environment Scale (TES)
por: Pérez-Sales, Pau, et al.
Publicado: (2021)

Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia
por: Cucchi, David G.J., et al.
Publicado: (2020)

Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape
por: Hsieh, Ya-Ching, et al.
Publicado: (2021)

Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications
por: Hoffman, Lindsey M., et al.
Publicado: (2014)

The serodiagnostic potential of recombinant proteins TES–30 and TES–120 in an indirect ELISA in the diagnosis of toxocariasis in cattle, horses, and sheep
por: dos Santos, Lucas Moreira, et al.
Publicado: (2019)

Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
por: Arnone, Claudia Manuela, et al.
Publicado: (2021)

Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma
por: Steponaitis, Giedrius, et al.
Publicado: (2016)

First sensitivity limits of the ALPS TES detector
por: Dreyling-Eschweiler, Jan
Publicado: (2014)

Focal plane with phased arrays TES (20')
por: O'Brient, Roger
Publicado: (2016)

BiTE secretion from in situ-programmed myeloid cells results in tumor-retained pharmacology
por: Hao, S., et al.
Publicado: (2022)

Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia
por: Melo Garcia, Luciana, et al.
Publicado: (2021)

Harnessing CD3 diversity to optimize CAR T cells
por: Velasco Cárdenas, Rubí M.-H., et al.
Publicado: (2023)

Hypersensitivity Reaction to a Mosquito Bite in a Patient with Chronic Myeloid Leukemia
por: Dior, Uri P., et al.
Publicado: (2011)

Perspective: Disentangling the effects of tES on neurovascular unit
por: Arora, Yashika, et al.
Publicado: (2023)

CD7 CAR: sword and shield
por: Velasquez, M. Paulina, et al.
Publicado: (2022)

CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
por: Mardiana, Sherly, et al.
Publicado: (2020)

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
por: Pasvolsky, Oren, et al.
Publicado: (2022)

A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia
por: Christodoulou, Ilias, et al.
Publicado: (2023)

CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
por: Zarychta, Julia, et al.
Publicado: (2023)

CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023)

Epigenetic treatment and beyond in acute myeloid leukemia
por: Wei, Andrew
Publicado: (2018)

Novel Immune Engagers and Cellular Therapies for Metastatic Castration-Resistant Prostate Cancer: Do we take a BiTe or ride BiKEs, TriKEs, and CARs?
por: Zorko, Nicholas A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_da06eu4r4mqtfr86nuo7qtn4ul